Skip to main content
Christopher Dvorak, MD, Pediatric Hematology & Oncology, San Francisco, CA, UCSF Medical Center

ChristopherDvorakMD

Pediatric Hematology & Oncology San Francisco, CA

Professor, Pediatrics, UCSF School of Medicine

Dr. Dvorak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dvorak's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2002 - 2005
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1998 - 2001
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2024
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • Effect of Levofloxacin Prophylaxis on Bacteremia in Children with Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation  
    L Charles Bailey, Aditya H Gaur, Michael L Nieder, Michael Green, Christopher C Dvorak, JAMA
  • Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma  
    Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

  • Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency
    Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants
    Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis
    Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Career-Development Lunch Sessions: Pediatric Clinical Malignant Hematology/BMT 
    60th American Society of Hematology Annual Meeting - 12/1/2018

Press Mentions

  • Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in Kids
    Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsNovember 18th, 2021

Hospital Affiliations